The Veterinary vaccines market is gaining prominence owing to the increasing adoption of companion animals worldwide. Veterinary vaccines help prevent various diseases affecting livestock animals and pets. They aid in controlling the spread of infectious diseases and boost animal health. The growing companion animal population and rising awareness regarding animal health have fueled the demand for veterinary vaccines.

The veterinary vaccines market is estimated to be valued at USD 10.46 Bn in 2025 and is expected to reach USD 17.70 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032.

Key Takeaways

Key players operating in the veterinary vaccines market are Aratana Therapeutics Inc., Regeneus Ltd., Morphogenesis Inc., Karyopharm Therapeutics Inc., Zoetis Inc., Eli Lilly and Company, Merck & Co. Inc., Boehringer Ingelheim GmbH., Elanco Animal Health, Virbac, Hester Biosciences Limited, Ceva Sante Animale, Phibro Animal Health Corporation, Kemin Industries, Inc., Finlab, Vaxxinova, Vira Vaccine Shaya, and VETERQUIMICA SA. Zoetis Inc. captured the largest market share in 2021 and offers a wide range of livestock and companion animal vaccines.

The Veterinary Vaccines Market Demand  are increasing global companion animal population for veterinary vaccines. According to the American Veterinary Medical Association, over 85 million cats and over 80 million dogs were living in US households in 2021. Growing human-animal bonding and rising incomes have increased pet adoption in several countries.

Technological advancements in veterinary vaccine development include advanced adjuvants, live-vector vaccines, recombinant vaccines, and thermostable labels. Companies are focusing on developing next-gen vaccines with thermostable properties to enable easy transportation and storage, especially in remote areas.

Market Trends

Growing Demand for Therapeutic Vaccines - There is increasing focus on developing therapeutic vaccines to treat cancers, metabolic disorders, and chronic infections prevalent in animals. Additionally, therapeutic vaccines to boost pets' immune systems and decrease the risk of various cancers are gaining traction.

Increasing Usage of AI and Big Data - Companies are utilizing AI, machine learning, and big data to accelerate vaccine development processes, analyze epidemiological trends, and predict disease outbreaks. AI aids in optimizing production processes and reducing the time taken to develop and commercialize new vaccines.

Market Opportunities

Development of Vaccines Targeting Emerging Diseases - With evolving pathogens and emergence of new infectious diseases, there is need to develop vaccines to curb zoonotic diseases at the human-animal interface. This provides opportunities for companies to develop vaccines combating emerging diseases.

Increasing Demand in Developing Regions - Regions such as Asia Pacific, Latin America, and Africa have seen rising demand for inexpensive, heat-tolerant veterinary vaccines. Leading players are focusing on developing economical vaccines and building distribution channels in these regions.

Impact of COVID-19 on Veterinary Vaccines Market Growth

The COVID-19 pandemic has impacted the growth of the veterinary vaccines market. In the initial months of the pandemic, restrictions on veterinary practices and diversion of resources towards the healthcare of infected humans resulted in lower demand and reduced availability of vaccines. Disruptions in supply chains led to shortages of raw materials and vaccine products. This led to delays in routine vaccination programs for livestock and companion animals. However, as the pandemic continued, veterinary practices adapted their protocols and cautious operations resumed with preventive measures. Teleconsultation also enabled continued care and advice to pet owners. The critical importance of vaccination was recognized to prevent outbreaks of zoonotic and livestock diseases. Government and industry bodies supported continued vaccination drives. It is expected that pent-up demand and catch-up vaccination programs post pandemic will drive the market. Industry players are collaborating to boost production capacity and ensure security of supply. Advances in thermostable and single-dose vaccines are expected to further aid vaccination programs in remote areas.

Geographical Regions

North America accounts for the largest share of the global veterinary vaccines market in terms of value. This is attributed to factors such as high companion animal ownership, advanced livestock management practices, stringent regulations regarding vaccination of food-producing animals and government support for research. Europe is the second largest market benefitting from organized veterinary healthcare systems and growing incidence of zoonotic diseases. Asia Pacific is poised to be the fastest growing region due to rising awareness, increasing meat consumption and government initiatives to curb epidemic livestock diseases impacting farm productivity and trade. Countries with large animal populations like India and China are majorly driving the regional market growth. Latin America and Middle East & Africa are emerging lucrative regions with increasing focus on animal health and welfare.

Get More Insights - Veterinary Vaccines Market

Get This Report in Japanese Language -  獣医用ワクチン市場

Get This Report in Korean Language -수의학 백신 시장

About Author:

Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.

(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)